17-4740923-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001136046.3(ZMYND15):āc.375A>Gā(p.Glu125Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.001 in 1,581,224 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0051 ( 5 hom., cov: 33)
Exomes š: 0.00057 ( 6 hom. )
Consequence
ZMYND15
NM_001136046.3 synonymous
NM_001136046.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.429
Genes affected
ZMYND15 (HGNC:20997): (zinc finger MYND-type containing 15) This gene encodes a MYND-containing zinc-binding protein with a nuclear localization sequence. A similar gene in mice has been shown to act as a testis-specific transcriptional repressor by recruiting histone deacetylase enzymes to regulate spatiotemporal expression of many haploid genes. This protein may play an important role in spermatogenesis. Alternative splicing results in multiple transcript variants and protein isoforms. [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 17-4740923-A-G is Benign according to our data. Variant chr17-4740923-A-G is described in ClinVar as [Benign]. Clinvar id is 790174.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.429 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00508 (774/152324) while in subpopulation AFR AF= 0.0177 (735/41572). AF 95% confidence interval is 0.0166. There are 5 homozygotes in gnomad4. There are 356 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZMYND15 | NM_001136046.3 | c.375A>G | p.Glu125Glu | synonymous_variant | 2/14 | ENST00000433935.6 | NP_001129518.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZMYND15 | ENST00000433935.6 | c.375A>G | p.Glu125Glu | synonymous_variant | 2/14 | 2 | NM_001136046.3 | ENSP00000391742.1 |
Frequencies
GnomAD3 genomes AF: 0.00501 AC: 763AN: 152206Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
763
AN:
152206
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00149 AC: 317AN: 212742Hom.: 2 AF XY: 0.00104 AC XY: 119AN XY: 114688
GnomAD3 exomes
AF:
AC:
317
AN:
212742
Hom.:
AF XY:
AC XY:
119
AN XY:
114688
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000567 AC: 810AN: 1428900Hom.: 6 Cov.: 31 AF XY: 0.000513 AC XY: 363AN XY: 706984
GnomAD4 exome
AF:
AC:
810
AN:
1428900
Hom.:
Cov.:
31
AF XY:
AC XY:
363
AN XY:
706984
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00508 AC: 774AN: 152324Hom.: 5 Cov.: 33 AF XY: 0.00478 AC XY: 356AN XY: 74490
GnomAD4 genome
AF:
AC:
774
AN:
152324
Hom.:
Cov.:
33
AF XY:
AC XY:
356
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 16, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at